Mr. Patrick Lee Behm, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1001 Bellefontaine Ave, Lima, OH 45804 Phone: 419-228-3335 Fax: 419-998-4514 |
Dr. Jorge L Sifuentes, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1001 Bellefontaine Ave, Lima, OH 45804 Phone: 419-228-3335 |
Dr. Robert W Moon, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 730 W Market Street, Lima, OH 45801 Phone: 419-227-3361 |
Dr. Mark A Wangler, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 730 W Market St, Lima, OH 45801 Phone: 419-227-3361 |
Aleksey A Prok, M.D Anesthesiology - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1003 Bellefontaine Ave Ste 100, Lima, OH 45804 Phone: 419-998-8234 |
Dr. Michael J Schneider, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 730 W Market Street, Lima, OH 45801 Phone: 419-227-3361 |
News Archive
Researchers from the UK recently developed a real-time machine learning framework that uses dynamic patient contact networks to predict hospital-onset COVID-19 infections (HOCIs) at the patient level. They then tested and validated the framework on international multi-site datasets across various epidemic and endemic periods. This study can be found on the medRxiv* preprint server.
Popping the blisters on the bubble wrap might be the most enjoyable thing about moving. But now, scientists propose a more productive way to reuse the popular packing material - as a sheet of small, test tube-like containers for medical and environmental samples.
Each year, thousands of Canadian men with prostate cancer undergo biopsies to help their doctors better understand the progression and nature of their disease. It provides vital, sometimes life-saving information, yet cancer researcher John Lewis knows it can be a difficult test to ask of anyone.
Inex Pharmaceuticals announced today that United States Food and Drug Administration (FDA) provided an action letter detailing that the anticancer drug Marqibo (vincristine sulfate liposomes injection) is "not approvable" under the FDA's accelerated approval regulations based on the phase 2 clinical trial data submitted.
› Verified 7 days ago